We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

77 ELEKTRONIKA

Develops, manufactures, and markets fully automated and semi-automated urine analyzers, rapid test readers and their ... read more Featured Products: More products

Download Mobile App





77 Elektronika Highlights Latest Urinanalysis Solutions at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023

77 Elektronika (Budapest, Hungary) is participating at Medlab Middle East 2023 where the company is showcasing its full product range, including its latest urine test strip - the LabStrip U12 mALB/CREA - alongside the new DocUReader 2 Pro urine analyzer. More...

At Medlab Middle East 2023, 77 Elektronika is demonstrating the LabStrip U mALB/CREA urine test strips designed for the semi-quantitative determination of albumin and creatinine in fresh human urine and the screening of samples for microalbuminuria. LabStrip U mALB/CREA is intended to be used as a screening test for the detection of pathologies associated with kidney diseases. Each test strip contains two test zones, which incorporate sensitive chemicals. If these zones come into contact with urine, a chemical reaction takes place, which results in the discoloration of the test zone.

The urine test strips can be evaluated and read on the new DocUReader 2 Pro urine analyzer that is also on display at the show. The instrument is intended for in vitro diagnostic use by qualified physicians and laboratory staff, but does not require special training to be used. The compact design of this lightweight instrument offers the broadest features and highest flexibility available on any desktop size urine analyzer. The system offers excellent accuracy, simple operation, high flexibility and connectivity as well as enhanced security and quality control functions.

In addition, 77 Elektronika is showcasing the LabUMat 2 and Urised 3 Pro that combines chemistry and sediment analysis in one system. The LabUMat 2 is a high throughput, automated urine chemistry analyzer that can evaluate 10 chemical parameters of LabStrip U11 Plus GL test strips and three physical parameters of urine samples. The UriSed 3 is an automated urine sediment analyzer providing whole field of view microscopic images of urine sediment and detecting 16 sediment particles using Urised Cuvettes. The efficiencies of the LabUMat 2 and the UriSed 3 are maximized when these instruments are used as one system.

Related Links:
77 Elektronika 


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.